Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
Holding DNA?
Track your performance easily
DNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.26 - $75.16
Previous Close$7.99
Volume841.27K
Average Volume (3M)1.38M
Market Cap
$424.04M
Enterprise Value$145.94M
Total Cash (Recent Filing)$730.37M
Total Debt (Recent Filing)$452.26M
Price to Earnings (P/E)―
Beta2.93
Next Earnings
Nov 12, 2024EPS Estimate
-$2.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.03
Shares Outstanding55,575,385
10 Day Avg. Volume797,553
30 Day Avg. Volume1,378,751
Standard Deviation0.23
R-Squared0.07
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)0.53
Price to Sales (P/S)2.30
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.79
Enterprise Value/Gross Profit0.74
Enterprise Value/Ebitda-0.19
Forecast
1Y Price Target
$8.50Price Target Upside2.29% Upside
Rating ConsensusHold
Number of Analyst Covering4
Ginkgo Bioworks Holdings News
Bulls Say, Bears Say
Bulls Say
AI Infrastructure ExpansionThe launch of Ginkgo's third new AI asset is another encouraging sign the company is executing on its push to build out its AI infrastructure and expand their tools service franchise.
Financial Performance2Q revenue of $56M came in above expectations, indicating strong performance in Cell Engineering and Biosecurity.
Strategic PartnershipsDNA's signing of its first LDaaS deals with a large tech company highlights new partnership opportunities and revenue streams.
Bears Say
Financial PerformanceHigher expenses in the quarter led to an adjusted EBITDA loss of $(99) million compared to expectations.
Growth And StrategyThe viability of its new commercial strategies remains to be determined.
Sales And ProfitabilityVisibility into both sales trends and profitability are still severely limited, with no clear resolution in sight.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DNA FAQ
What was Ginkgo Bioworks Holdings’s price range in the past 12 months?
Ginkgo Bioworks Holdings lowest stock price was $5.26 and its highest was $75.16 in the past 12 months.
What is Ginkgo Bioworks Holdings’s market cap?
Currently, no data Available
When is Ginkgo Bioworks Holdings’s upcoming earnings report date?
Ginkgo Bioworks Holdings’s upcoming earnings report date is Nov 12, 2024 which is in 5 days.
How were Ginkgo Bioworks Holdings’s earnings last quarter?
Ginkgo Bioworks Holdings released its earnings results on Aug 08, 2024. The company reported -$4.4 earnings per share for the quarter, missing the consensus estimate of -$3.098 by -$1.302.
Is Ginkgo Bioworks Holdings overvalued?
According to Wall Street analysts Ginkgo Bioworks Holdings’s price is currently Undervalued.
Does Ginkgo Bioworks Holdings pay dividends?
Ginkgo Bioworks Holdings does not currently pay dividends.
What is Ginkgo Bioworks Holdings’s EPS estimate?
Ginkgo Bioworks Holdings’s EPS estimate is -$2.73.
How many shares outstanding does Ginkgo Bioworks Holdings have?
Ginkgo Bioworks Holdings has 43,103,012 shares outstanding.
What happened to Ginkgo Bioworks Holdings’s price movement after its last earnings report?
Ginkgo Bioworks Holdings reported an EPS of -$4.4 in its last earnings report, missing expectations of -$3.098. Following the earnings report the stock price went down -5.424%.
Which hedge fund is a major shareholder of Ginkgo Bioworks Holdings?
Among the largest hedge funds holding Ginkgo Bioworks Holdings’s share is Viking Global Investors LP. It holds Ginkgo Bioworks Holdings’s shares valued at 48M.
---
Ginkgo Bioworks Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.50 (2.29% Upside)
$8.50 (2.29% Upside)
Blogger Sentiment
Bullish
DNA Sentiment 60%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 4.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.82%
12-Months-Change
Fundamentals
Return on Equity
-76.83%
Trailing 12-Months
Asset Growth
-29.09%
Trailing 12-Months
Company Description
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings (NYSE:DNA) is a biotechnology company that offers a platform for cell programming that enables the biological production of various products across the food, pharmaceutical, and fragrance industry. Its platform provides equipment, software, robotic automation, and tools to support genetic engineering, analytics, and fermentation.
---
DNA Company Deck
---
DNA Earnings Call
Q2 2024
0:00 / 0:00
---
DNA Revenue Breakdown
57.08% Cell Engineering
42.92% Biosecurity
---
DNA Stock 12 Month Forecast
Average Price Target
$8.50
▲(2.29% Upside)
Technical Analysis
Twist Bioscience
―
Sorrento Therapeutics
―
Intellia Therapeutics
―
Sangamo Biosciences
―
Best Analysts Covering DNA
1 Year
1 Year Success Rate
6/6 ratings generated profit
1 Year Average Return
+60.22%
reiterated a sell rating 3 months ago
Copying Matthew Sykes's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +60.22% per trade.
---